Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(50)
•••
Comment by BLSH101on Sep 24, 2018 3:29pm
304 Views
Post# 28679893

RE:RE:NEWS FROM IR - LICENSE BEFORE END OF OCTOBER!!!

RE:RE:NEWS FROM IR - LICENSE BEFORE END OF OCTOBER!!!
RE: LICENSE
investor relations <ir@fsdpharma.com>
Mon 2018-09-24, 11:32 AM
 
 

Hi,

Thanks for the kind words. This is where we stand with the sales license :

  • Our second crop has been completed and taken for testing on behalf of health Canada, since early this September. Currently the company is being reviewed at the pre-sales license inspection stage (last stage before sales license issuance).
  • Some previous lab results has health Canada up to 2 months for them to follow up on, and they don’t give companies exact dates on to when they will respond to the applications.
  • For a very rough estimate we should have response by sometime October.
  • It’s a priority the sales license and we are following up with health Canada as closely as we can.
  •  

Thanks for waiting patiently harry,

 

Let me know if there is anything else I can answer for you

 

Sent from Mail for Windows 10

 


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities